Difference between revisions of "Lestaurtinib (CEP-701)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "Category:Chemotherapeutic" to "")
m (Text replacement - "Category:Kinase inhibitors" to "")
Line 4: Line 4:
  
  
[[Category:Kinase inhibitors]]
+
 
 
[[Category:FLT3 inhibitors]]
 
[[Category:FLT3 inhibitors]]
 
[[Category:JAK inhibitors]]
 
[[Category:JAK inhibitors]]
  
 
[[Category:Investigational drugs]]
 
[[Category:Investigational drugs]]

Revision as of 23:01, 28 February 2020

In clinical trials.